BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26491664)

  • 41. Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications.
    Angulo P; Machado MV; Diehl AM
    Semin Liver Dis; 2015 May; 35(2):132-45. PubMed ID: 25974899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. m
    Qin Y; Li B; Arumugam S; Lu Q; Mankash SM; Li J; Sun B; Li J; Flavell RA; Li HB; Ouyang X
    Cell Rep; 2021 Nov; 37(6):109968. PubMed ID: 34758326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sleep apnea hypopnea syndrome and liver injury.
    Tian JL; Zhang Y; Chen BY
    Chin Med J (Engl); 2010 Jan; 123(1):89-94. PubMed ID: 20137582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. There's more under the nonalcoholic fatty liver disease umbrella than an elevated alanine aminotransferase level.
    Kohli R
    J Pediatr; 2014 Apr; 164(4):684-6. PubMed ID: 24461787
    [No Abstract]   [Full Text] [Related]  

  • 45. OX40 Regulates Both Innate and Adaptive Immunity and Promotes Nonalcoholic Steatohepatitis.
    Sun G; Jin H; Zhang C; Meng H; Zhao X; Wei D; Ou X; Wang Q; Li S; Wang T; Sun X; Shi W; Tian D; Liu K; Xu H; Tian Y; Li X; Guo W; Jia J; Zhang Z; Zhang D
    Cell Rep; 2018 Dec; 25(13):3786-3799.e4. PubMed ID: 30590049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nocturnal hypoxia in obese-related obstructive sleep apnea as a putative trigger of oxidative stress in pediatric NAFLD progression.
    Parola M; Vajro P
    J Hepatol; 2016 Sep; 65(3):470-2. PubMed ID: 27501737
    [No Abstract]   [Full Text] [Related]  

  • 47. Hypoxia-inducible factors and innate immunity in liver cancer.
    Yuen VW; Wong CC
    J Clin Invest; 2020 Oct; 130(10):5052-5062. PubMed ID: 32750043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hypoxia, inflammation and phenotypic plasticity of macrophages: the central role of HIF-1 and NFkappaB].
    Malyshev IIu; Kruglov SV; Liamina SV
    Patol Fiziol Eksp Ter; 2012; (3):42-50. PubMed ID: 23072111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance.
    Nishio N; Isobe K
    Sci Rep; 2015 Aug; 5():13519. PubMed ID: 26316333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of circulating markers of hepatic apoptosis and inflammation in obese children with and without obstructive sleep apnea.
    Alkhouri N; Kheirandish-Gozal L; Matloob A; Alonso-Álvarez ML; Khalyfa A; Terán-Santos J; Okwu V; Lopez R; Gileles-Hillel A; Dweik R; Gozal D
    Sleep Med; 2015 Sep; 16(9):1031-5. PubMed ID: 26298775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
    Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.
    Stojsavljević S; Gomerčić Palčić M; Virović Jukić L; Smirčić Duvnjak L; Duvnjak M
    World J Gastroenterol; 2014 Dec; 20(48):18070-91. PubMed ID: 25561778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The effect of chronic intermittent hypoxia caused by obstructive sleep apnea hypopnea syndrome on blood pressure].
    Mo L; Gai J; He QY
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Dec; 30(12):898-903. PubMed ID: 18336764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Developmental Programming of Nonalcoholic Fatty Liver Disease: The Effect of Early Life Nutrition on Susceptibility and Disease Severity in Later Life.
    Li M; Reynolds CM; Segovia SA; Gray C; Vickers MH
    Biomed Res Int; 2015; 2015():437107. PubMed ID: 26090409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
    Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
    Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Moderate physical activity promotes basal hepatic autophagy in diet-induced obese mice.
    Rosa-Caldwell ME; Lee DE; Brown JL; Brown LA; Perry RA; Greene ES; Carvallo Chaigneau FR; Washington TA; Greene NP
    Appl Physiol Nutr Metab; 2017 Feb; 42(2):148-156. PubMed ID: 28084795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice.
    Handa P; Morgan-Stevenson V; Maliken BD; Nelson JE; Washington S; Westerman M; Yeh MM; Kowdley KV
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(2):G117-27. PubMed ID: 26564716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model.
    Enos RT; Velázquez KT; McClellan JL; Cranford TL; Walla MD; Murphy EA
    Nutr Res; 2015 May; 35(5):449-59. PubMed ID: 25934114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypoxia and fatty liver.
    Suzuki T; Shinjo S; Arai T; Kanai M; Goda N
    World J Gastroenterol; 2014 Nov; 20(41):15087-97. PubMed ID: 25386057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
    Mantovani A; Gisondi P; Lonardo A; Targher G
    Int J Mol Sci; 2016 Feb; 17(2):217. PubMed ID: 26861300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.